OKYO · NASDAQ · Biotechnology

OKYO Pharma (OKYO)

Develops urcosimod eye drops for neuropathic corneal pain and anterior-segment eye diseases.

$1.33
vs last close−0.02 (−1.48%)
  1. What Makes OKYO Pharma (OKYO) a New Buy Stock

    Zacks Investment Research